Repligen

RGEN • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $151,346 $155,743 $141,192 $159,169
Gross Profit 74,955 67,607 36,558 79,862
EBITDA 15,503 19,618 -29,048 21,261
EBIT -1,288 -11,521 4,808 19,399
Net Income 2,094 -25,488 18,172 20,064
Net Change In Cash 151,346 155,743 141,192 159,169
Free Cash Flow 36,335 17,948 30,184 25,077
Cash 780,617 751,323 630,779 603,656
Basic Shares 56,531 55,815 56,940 56,858

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $638,764 $801,536 $670,534 $366,260
Gross Profit 284,247 455,706 391,254 209,626
EBITDA 131,390 184,595 171,946 69,609
EBIT 63,305 133,610 133,499 42,542
Net Income 41,577 185,959 128,291 59,926
Net Change In Cash 638,764 801,536 670,534 366,260
Cost of Revenue -74,490 -113,478 179,885
Free Cash Flow 74,930 38,737 47,740 36,281
Cash 751,323 523,458 603,814 717,292
Basic Shares 56,377 57,455 57,264 53,892

Earnings Calls

Quarter EPS
2024-03-31 $0.28
2023-12-31 $0.33
2023-09-30 $0.23
2023-06-30 $0.53